Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Inan

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biotechnology and Applied Biochemistry|December 3, 2024
Cell line development and bioreactor process optimization for an atezolizumab biosimilarAyca Zeybek Kuyucu, Dogu Sayili, Ridvan Orkut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Gene signatures of progression and metastasis in renal cell cancerJon Jones, Hasan Otu, Dimitrios Spentzos, et al.
Protein Expression and Purification|October 12, 2010
Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastorisMichael P Dux, Jicai Huang, Rick Barent, et al.
Journal of Biotechnology|October 3, 2006
Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(H(c)): antigen E) by Pichia pastorisJayanta Sinha, Mehmet Inan, Sarah Fanders, et al.
Biotechnology Progress|June 2, 2011
Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin A-chain vaccine-RVEc™Michael M Meagher, Javier G Seravalli, S Todd Swanson, et al.
Protein Expression and Purification|October 11, 2005
Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris GS115Michael P Dux, Rick Barent, Jayanta Sinha, et al.
Microbial Biotechnology|January 16, 2025
Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastorisSibel Kalyoncu, Dogu Sayili, Ayca Zeybek Kuyucu, et al.
International Journal for Parasitology|September 19, 2003
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine InitiativePeter J Hotez, Bin Zhan, Jeffrey M Bethony, et al.
Scientific Reports|March 30, 2023
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastorisSibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biotechnology and Applied Biochemistry|December 3, 2024
Cell line development and bioreactor process optimization for an atezolizumab biosimilarAyca Zeybek Kuyucu, Dogu Sayili, Ridvan Orkut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Gene signatures of progression and metastasis in renal cell cancerJon Jones, Hasan Otu, Dimitrios Spentzos, et al.
Protein Expression and Purification|October 12, 2010
Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastorisMichael P Dux, Jicai Huang, Rick Barent, et al.
Journal of Biotechnology|October 3, 2006
Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(H(c)): antigen E) by Pichia pastorisJayanta Sinha, Mehmet Inan, Sarah Fanders, et al.
Biotechnology Progress|June 2, 2011
Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin A-chain vaccine-RVEc™Michael M Meagher, Javier G Seravalli, S Todd Swanson, et al.
Protein Expression and Purification|October 11, 2005
Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris GS115Michael P Dux, Rick Barent, Jayanta Sinha, et al.
Microbial Biotechnology|January 16, 2025
Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastorisSibel Kalyoncu, Dogu Sayili, Ayca Zeybek Kuyucu, et al.
International Journal for Parasitology|September 19, 2003
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine InitiativePeter J Hotez, Bin Zhan, Jeffrey M Bethony, et al.
Scientific Reports|March 30, 2023
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastorisSibel Kalyoncu, Semiramis Yilmaz, Ayca Zeybek Kuyucu, et al.
Pageof 4